Viewing data from:

PERCOCET

ANDA

ACETAMINOPHEN; OXYCODONE HYDROCHLORIDE | A040330 | OZANTRI LTD

4 strengths0 unique patents0 unique exclusivities

Medicare Part D Spending

CMS annual spending data for Percocet (2023)

Total Spending

$65.0M

Total Claims

17,908

Beneficiaries

2,338

Avg Cost/Unit

$32.85

Spending Trend

$53.5M(2019)→$56.6M(2020)→$56.6M(2021)→$60.1M(2022)→$65.0M(2023)

YoY Change:+11.4%

5yr CAGR:+10.9%

Source: CMS Medicare Part D Spending by Drug (2023). Shows gross drug cost under Part D.

Approval Letters

1 letter from Drugs@FDA

Date	Submission	Document
Jun 25, 1999	ORIG -1	View Letter (PDF)

Source: Drugs@FDA application documents.

Products (4)

Sort:

#001 — 325MG;2.5MG

0 patents0 exclusivities▴

TABLET;ORAL | Approved: Jun 25, 1999

No patent or exclusivity listings for this strength.

#002 — 325MG;5MG

0 patents0 exclusivities▾

TABLET;ORAL | Approved: Jun 25, 1999

#003 — 325MG;7.5MG

0 patents0 exclusivities▾

TABLET;ORAL | Approved: Nov 23, 2001

#004 — 325MG;10MG

0 patents0 exclusivities▾

TABLET;ORAL | Approved: Nov 23, 2001